menu icon
Coronavirus (COVID-19) Latest news

Different course options

Full time | University of Strathclyde | 12 months | SEP

Study mode

Full time

Duration

12 months

Start date

SEP

Key information
DATA SOURCE : IDP Connect

Qualification type

MSc - Master of Science

Subject areas

Oncology

Course type

Taught

Course Summary

Why this course?

The MSc in Cancer Therapies is unique in the UK. It's a multifaceted course and the only one which combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology. You'll also gain an understanding of the practical, ethical and economic implications of personalised cancer therapy. The degree is for graduates seeking experience in the range of topics essential to the understanding and development of cancer therapies.

You'll be taught in the Strathclyde Institute of Pharmacy & Biomedical Sciences, recognised as one of the leading departments of its kind in the UK. The Institute has major facilities for radiobiology and radiopharmaceutical research. It also hosts the Cancer Research UK Drug Formulation Unit – the only one of its kind in the UK. You'll therefore be taught by researchers working at the forefront of basic, translational, industrial and clinical cancer research in the biomedical and physical sciences arenas.

The course has been developed to produce world-class graduates with the skills to contribute to the global drive in advancing cancer treatment through research, teaching, industry and public sector employment.

What you'll study

Studying with us will provide you with the skills to assess, analyse, critically appraise and evaluate current and emerging anti-cancer therapies and the drug discovery cascade – from target evaluation and engagement to clinical trials.

The course will also provide you with the specialist research training and a breadth of skills needed for your future career. It's been designed in response to a growing demand from academia, industry and health care providers for a course which focuses on current and emerging cancer therapies, in a format which covers essential multidisciplinary aspects of the topic.

By the end of this course you will:

  • have a working knowledge of the range of topics in biology, physical sciences and radiobiology to prepare you for a career in cancer therapies
  • understand the principles of developing drugs for cancer therapies; this is highly relevant for therapy development in other diseases
  • be able to carry out independent work of a publishable standard
  • gain unique skills suitable for a career in the pharmaceutical or health care industries
  • be able to continue your research career into a PhD programme

The generic skills you'll gain will help you excel in your future career and also provide specialist subject experience in:

  • personalised cancer medicine in the global context
  • radiotherapy as a diagnostic and as a single or combinational treatment with drugs.
  • current and future radiotherapy provision, nuclear medicine and radiopharmacueticals
  • the challenges of drug discovery, formulation and delivery enabling you to evaluate the drug discovery pipeline including:
  • the opportunity to develop anti-cancer agents
  • medicinal chemistry
  • screening
  • secondary assays

Careers

Sectors

The MSc in Cancer Therapies is designed for those wishing to pursue careers in:

  • healthcare
  • academia (research and teaching)
  • scientific research
  • industry

The course offers unique content which spans the entire cancer therapies spectrum from basic biology and genetics to drug design, delivery and radiotherapy. It provides an excellent base for traversal to many career destinations in the cancer field.

The course by its design also will enable graduates to apply this knowledge to other diseases and research fields in the biological, healthcare and physical sciences arena. After graduating you'll be ideally qualified for positions in biomedical and pharmaceutical industries as well as hospitals and universities.

Modules

Find out from the experts what it takes to translate bright ideas in cancer science into patents, business plans and spin-out companies. This is another key skill in cancer research as often the route to translation of your big idea from the laboratory is to engage with companies to enable funding to take these concepts forward in to the clinic. This class offers a unique opportunity for you to bring this knowledge to the benefit of any cancer therapies development team and enhances your skill set and employability.

Tuition fees

UK fees
Course fees for UK / EU students

For this course (per year)

£8,100

Average for all Postgrad courses (per year)

£5,202

International fees
Course fees for non-UK / EU students

For this course (per year)

£20,350

Average for all Postgrad courses (per year)

£12,227

Entry requirements

Minimum second-class Honours degree, or international equivalent in a science or health-related subject Students with alternative entry standards or professional experience may also be considered and are usually admitted in the first instance to the Diploma course. Upon satisfactory completion of all Semester 1 assessment, these students will be offered the chance to transfer to the MSc programme.

University information

The University of Strathclyde were awarded the Queen’s Anniversary Prize, the highest national honour awarded to our sector. They are transforming our campus to create a first -class working learning environment. Their new £31 million Strathclyde Sport building provides a range of sport and wellbeing facilities for students, staff and the local community. The Centre offers state-of-the art training facilities, including a 25-metre swimming...more

Similar courses at this uni